With the COVID-19 pandemic still prevalent around the world, scientists are working tirelessly to develop a vaccine. Two vaccines have recently made headlines for their promising results.
“One of the vaccines is being produced by AstraZeneca and is being studied in the University of Oxford, while the other is being produced by a Chinese pharmaceutical company, CanSino Biologics in the Beijing Institute of Biotechnology. Both of the vaccines have had promising initial immune responses.”
All of the participants who received the AstraZeneca vaccine developed antibodies within 2 weeks, with 32 out of the 35 participants even developing antibodies after a single dose. Similarly, 95% of the CanSino Biologics vaccine participants showed immune responses 28 days after vaccination. There were no serious adverse reactions reported in either study.
Although much more research will be necessary, the studies both provide a solid framework for future studies to take place.
To read more about both vaccines, please click here.
